Home › Hemato-oncology › Leukemia Treatment
Leukemia is a type of blood cancer that begins in the blood-forming tissues, mainly the bone marrow.
It affects the development and function of blood cells and can interfere with the body’s ability to fight infections, carry oxygen and control bleeding. Leukemia is not a single disease. Different types can develop and progress differently, so diagnosis and treatment need to be planned according to the specific type and characteristics of the disease.
At Karnawat Cancer Hospital, patients with suspected or diagnosed leukemia can receive evaluation and cancer care based on their individual condition. Understanding the type of leukemia, its extent and relevant laboratory or molecular findings helps the oncology team determine an appropriate treatment approach.
Leukemia is a group of cancers that develop in the blood-forming tissues, particularly the bone marrow. In leukemia, abnormal blood cells grow and multiply uncontrollably, interfering with the production of healthy blood cells. As a result, the body may not produce enough normal red blood cells, white blood cells, or platelets, which can lead to anemia, frequent infections, easy bruising, or abnormal bleeding. Symptoms can vary depending on the type of leukemia and how quickly the disease develops.
Leukemia is broadly classified according to two factors:
This classification helps doctors understand the disease and select appropriate diagnostic tests and treatment options.
ALL develops from immature lymphoid cells and usually progresses rapidly. It can affect both children and adults, although it is more common among children.
AML develops from abnormal myeloid cells and typically progresses quickly. It is one of the most common types of acute leukemia diagnosed in adults.
CLL affects lymphocytes and generally progresses more slowly than acute leukemia. Some people may have few or no symptoms when initially diagnosed.
CML develops from abnormal myeloid cells and usually progresses slowly. Targeted medicines have significantly improved disease management and outcomes for many patients.
Several less common forms of leukemia can also occur. Identifying the specific leukemia subtype is important for accurate diagnosis, treatment planning and selecting appropriate treatment options.
The symptoms of leukemia can vary from person to person and may depend on the type of leukemia and how quickly it develops. Many symptoms occur because abnormal blood cells interfere with the normal production of healthy red blood cells, white blood cells and platelets.
Common symptoms may include persistent fatigue or weakness, fever or recurrent infections, easy bruising, frequent nosebleeds or bleeding gums, small red spots on the skin called petechiae, pale skin, shortness of breath, unexplained weight loss, night sweats, bone or joint pain, swollen lymph nodes and a feeling of fullness or discomfort in the abdomen. Some people may also experience frequent or persistent infections.
These symptoms do not necessarily indicate leukemia, as they can occur with many other health conditions. However, persistent, unexplained or worsening symptoms should be evaluated by a qualified healthcare professional. Appropriate medical evaluation and diagnostic tests are necessary to determine the underlying cause.
A complete blood count (CBC) evaluates red blood cells, white blood cells and platelets. A peripheral blood smear may also identify abnormal blood cells.
Bone marrow aspiration and biopsy examine cells within the bone marrow, helping doctors identify abnormal cells and determine the type and characteristics of leukemia.
Flow cytometry analyzes specific markers on abnormal blood cells. It helps doctors identify the type of leukemia and distinguish between different leukemia subtypes.
These tests detect chromosome and molecular changes associated with certain leukemia types. The results can help characterize the disease and guide targeted treatment decisions.
Depending on the leukemia type and individual circumstances, doctors may recommend imaging studies or lumbar puncture to assess possible brain or spinal cord involvement.
Chemotherapy: Chemotherapy uses medicines to destroy leukemia cells or slow their growth. It is an important treatment for several types of leukemia, particularly acute leukemias. The specific medicines, doses, combinations and treatment schedule depend on the leukemia subtype and treatment phase.
Targeted Therapy: Targeted therapy works against specific proteins, genes, or molecular changes that help leukemia cells grow and survive. It may be used when testing identifies a treatable target and is an important option for certain cases of CML, CLL and ALL.
Immunotherapy: Immunotherapy uses the immune system or immune-based treatments to recognize and attack leukemia cells. Depending on the leukemia type and treatment setting, it may include antibody-based medicines or cellular therapies such as CAR T-cell therapy for selected patients.
Stem Cell Transplant: Stem cell transplantation, also called hematopoietic stem cell transplantation, may be considered for selected patients with leukemia. In an allogeneic transplant, healthy blood-forming stem cells from a suitable donor replace diseased bone marrow. Suitability depends on disease characteristics and overall health.
Supportive Care: Supportive care helps manage complications and treatment-related problems during leukemia treatment. It may include treatment for infections, anemia, bleeding, nutritional concerns and other symptoms. Supportive or palliative care can also help manage symptoms and improve quality of life when appropriate.
Leukemia treatment can cause side effects, but they can vary from person to person depending on the type of treatment, dosage, combination of therapies and overall health. Some people may experience fatigue, nausea or vomiting, loss of appetite, hair loss, mouth sores, changes in taste or skin reactions. Treatment may also lower blood cell counts, which can increase the risk of infections, anemia, bruising or bleeding. Not everyone experiences the same side effects and their severity can vary. During treatment, the oncology team regularly monitors blood counts and overall health and may recommend medicines or supportive care to help manage these effects. Patients should inform their healthcare team about any new, persistent or severe symptoms so they can receive appropriate medical advice and timely treatment.
Choosing a cancer care facility for leukemia involves more than looking at the hospital name. Patients may need access to oncology consultation, accurate diagnosis, laboratory evaluation, chemotherapy and other appropriate treatment and supportive care depending on the type of leukemia.
Karnawat Cancer Hospital provides cancer care in Sambhajinagar for patients seeking evaluation and treatment for different types of cancer. Patients diagnosed with leukemia can discuss their diagnosis, test reports and available treatment options with the oncology team to understand the next steps.
If you are looking for a leukemia treatment hospital in Sambhajinagar or a leukemia treatment center in Sambhajinagar, an oncology consultation can help determine the appropriate diagnostic and treatment pathway based on the specific type of leukemia.
Leukemia is a group of blood cancers that develops in blood-forming tissues such as the bone marrow. It causes abnormal blood cells to multiply and can interfere with the production of healthy blood cells.
Common symptoms may include persistent fatigue, fever, recurrent infections, easy bruising or bleeding, pale skin, shortness of breath, unexplained weight loss, night sweats, bone or joint pain and swollen lymph nodes. These symptoms can also occur with other medical conditions and require proper medical evaluation.
There is no single treatment that is best for every type of leukemia. Treatment is selected according to the leukemia subtype, molecular characteristics, disease status, overall health and other clinical factors. Options may include chemotherapy, targeted therapy, immunotherapy and stem cell transplantation in selected cases.
Depending on the treatment, possible side effects can include fatigue, nausea, appetite changes, hair loss, mouth sores, low blood counts, infections and bleeding or bruising. Side effects vary between patients and should be monitored by the treating healthcare team.
Yes. Stem cell transplantation may be used for selected patients with certain types of leukemia. An allogeneic transplant uses healthy blood-forming stem cells from a donor. Whether transplant is appropriate depends on the leukemia type, disease characteristics, response to treatment and the patient’s overall health.
Some forms of leukemia can be cured, while others may be controlled for long periods or placed into remission. The possibility of remission or cure varies according to the type of leukemia and individual patient factors.
Persistent or unexplained symptoms such as unusual bleeding, frequent infections, prolonged fatigue, fever, unexplained weight loss or easy bruising should be evaluated by a healthcare professional. These symptoms do not automatically indicate leukemia, but they should not be ignored when they persist.
/lymphoma-treatment-Sambhajinagar/ Lymphoma Treatment
This page is for general information and does not replace a consultation. Treatment is decided by your oncologist after reviewing your reports.
Emergency & I.C.U. 24×7 · OPD 9 AM – 6 PM
Karnawat Cancer Hospital provides hemato-oncology care for patients with blood cancers and related blood and bone marrow disorders.
Lymphoma is a type of blood cancer that develops in the lymphatic system, which is an important part of the body’s immune system.
Multiple myeloma is a type of blood cancer that develops in plasma cells, a type of white blood cell responsible for producing antibodies.
Stem cell and bone marrow transplantation is a specialised medical procedure used to treat certain blood cancers, bone marrow disorders and…
Consultations, second opinions and treatment planning. Emergency and I.C.U. care 24 hours a day.
Share your details and our team will call you to confirm a time.